HIGHLIGHTS
- who: Bridget C Howard from the Centre at the University of New South Wales, Sydney, AustraliaParticipants are people who smoke daily, are interested have published the paper: Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial, in the Journal: (JOURNAL)
- what: This study evaluates the effectiveness safety and cost-effectiveness of VNPs (pod and tank device) compared with nicotine replacement therapy ([NRT]-gum or lozenge) for smoking cessation. The text message programme . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.